tiprankstipranks
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market
Holding MIST?
Track your performance easily

Milestone Pharmaceuticals (MIST) Income Statement

475 Followers

Milestone Pharmaceuticals Income Statement

Last quarter (Q3 2024), Milestone Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Milestone Pharmaceuticals's net income was $-9.44M. See Milestone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 1.00M$ 5.00M---
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 24.65M$ 62.10M$ 64.64M$ 44.07M$ 38.84M$ 40.10M
Operating Income
$ -43.55M$ -61.10M$ -59.64M$ -43.07M$ -50.71M$ -40.10M
Net Non Operating Interest Income Expense
$ 2.58M$ 1.41M$ 1.25M$ 220.00K--
Other Income Expense
-$ -1.00M$ -5.00M$ -15.00M$ -726.00K$ -2.60M
Pretax Income
$ -24.76M$ -59.69M$ -58.39M$ -28.85M$ -49.98M$ -37.50M
Tax Provision
$ 205.00K$ 205.00K$ 251.00K$ -1.00K$ -17.00K$ -56.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -42.77M$ -59.69M$ -58.39M$ -42.85M$ -49.97M$ -37.45M
Basic EPS
$ -0.81$ -1.39$ -1.38$ -1.02$ -1.70-
Diluted EPS
$ -0.81$ -1.39$ -1.38$ -1.02$ -1.70$ 3.50
Basic Average Shares
$ 250.42M$ 42.94M$ 42.31M$ 28.28M$ 29.34M$ 15.78M
Diluted Average Shares
$ 250.42M$ 42.94M$ 42.31M$ 28.28M$ 29.34M$ 15.78M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 27.00M$ 62.10M$ 64.64M$ 44.07M$ 38.84M$ 40.10M
Net Income From Continuing And Discontinued Operation
$ -42.77M$ -59.69M$ -58.39M$ -42.85M$ -49.97M$ -37.45M
Normalized Income
$ -22.35M$ -23.27M-$ -28.85M--
Interest Expense
------
EBIT
$ -37.27M$ -57.13M$ -58.39M$ -43.07M$ -50.71M$ -37.50M
EBITDA
$ -37.19M$ -57.04M$ -58.30M$ -42.98M$ -50.61M$ -37.46M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis